Advancement in Prostate Imaging

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Medical Imaging and Theranostics".

Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 2974

Special Issue Editors


E-Mail Website
Guest Editor
Department of Radiology, Urology and Nephrology Center, Mansoura University, Mansoura 35516, Egypt
Interests: urinary tract; infection; pyelonephritis; cystitis; MRI; bladder; imaging; diagnosis; prostate cancer; image processing; digital image analysis; artificial intelligence

E-Mail Website
Guest Editor
Urology and Nephrology Center, Mansoura University, Mansoura, Egypt
Interests: diagnostic and interventional urogenital radiology; abdominal radiology

Special Issue Information

Dear Colleagues,

Over the past several years, there are many advances in the field of prostate imaging especially in the diagnosis of prostate cancer. Advances in prostate imaging include Multiparametric MRI (mpMRI) as one example of an imaging modality that has recently been implemented to aid the diagnosis of cancer prostate including MRI guided biopsy with ultrasound/MRI image fusion. Additional encouraging innovations include the use of contrast-enhanced ultrasound, ultrasound elastography, and prostate-specific membrane antigen-directed positron emission tomography (PSMA-PET).

In recent years, Artificial intelligence (AI) has become the main player in the radiological detection, diagnosis, and management of diseases including prostate cancer. Implementing biomarkers, mpMRI findings including PI-RADs scoring system, and histopathology allowed great improvement in the diagnosis of prostate lesions as well the management plan.

This special issue aims to comprehensively cover all aspects of novel diagnostic imaging of prostate cancer including different imaging modalities as well the current role and future perspectives of AI.  

Dr. Mohamed Abou El-Ghar
Dr. Tarek El-Diasty
Prof. Dr. Ayman El-Baz
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 11181 KiB  
Review
Contemporary Review of Multimodality Imaging of the Prostate Gland
by Carli E. Calderone, Eric M. Turner, Omar E. Hayek, David Summerlin, Janelle T. West, Soroush Rais-Bahrami and Samuel J. Galgano
Diagnostics 2023, 13(11), 1860; https://doi.org/10.3390/diagnostics13111860 - 26 May 2023
Viewed by 2654
Abstract
Tissue changes and the enlargement of the prostate, whether benign or malignant, are among the most common groups of diseases that affect men and can have significant impacts on length and quality of life. The prevalence of benign prostatic hyperplasia (BPH) increases significantly [...] Read more.
Tissue changes and the enlargement of the prostate, whether benign or malignant, are among the most common groups of diseases that affect men and can have significant impacts on length and quality of life. The prevalence of benign prostatic hyperplasia (BPH) increases significantly with age and affects nearly all men as they grow older. Other than skin cancers, prostate cancer is the most common cancer among men in the United States. Imaging is an essential component in the diagnosis and management of these conditions. Multiple modalities are available for prostate imaging, including several novel imaging modalities that have changed the landscape of prostate imaging in recent years. This review will cover the data relating to commonly used standard-of-care prostate imaging modalities, advances in newer technologies, and newer standards that impact prostate gland imaging. Full article
(This article belongs to the Special Issue Advancement in Prostate Imaging)
Show Figures

Figure 1

Back to TopTop